<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36786598</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-6596</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>Antimicrobial agents and chemotherapy</Title><ISOAbbreviation>Antimicrob Agents Chemother</ISOAbbreviation></Journal><ArticleTitle>Antiviral Activity of <i>trans</i>-Hexenoic Acid against Coxsackievirus B and Enterovirus A71.</ArticleTitle><Pagination><StartPage>e0086822</StartPage><MedlinePgn>e0086822</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00868-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/aac.00868-22</ELocationID><Abstract><AbstractText>Enterovirus infections are life-threatening viral infections which occur mainly among children and are possible causes of viral outbreak. Until now, treatment and management of infections caused by members of the genus <i>Enterovirus</i> largely depended on supportive care, and no antiviral medications are currently approved for the treatment of most of these infections. The urgency of discovering new therapeutic options for the treatment of enterovirus infection is increasing. In the present study, we identified that <i>trans</i>-2-hexenoic acid (THA), a natural product from a dietary source, possesses antiviral activity against coxsackievirus B (CVB) and enterovirus A71 (EV-A71) in a dose-dependent manner. We found that THA possesses antiviral activity at 50% effective concentrations (EC<sub>50</sub>) of 2.9&#x2009;&#x3bc;M and 3.21&#x2009;&#x3bc;M against CVB3 and EV-A71 infections, respectively. The time of addition assay revealed that THA inhibits both CVB3 and EV-A71 replication at the entry stage of infection. Additional results from this study further suggest that THA inhibits viral replication by blocking viral entry. Given that THA has received approval as a food additive, treatment of enterovirus infections with THA might be a safe therapeutic option or could pave the way for semisynthetic manufacturing of more antiviral drugs in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Olasunkanmi</LastName><ForeName>Oluwatayo Israel</ForeName><Initials>OI</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fei</LastName><ForeName>Yanru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avala Ntsigouaye</LastName><ForeName>Juval</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jinchang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Weixu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Megeto</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Tahira</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Weizhen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lexun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wenran</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-2495-5138</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2081-3263</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Zhaohua</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-0778-5053</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Antimicrob Agents Chemother</MedlineTA><NlmUniqueID>0315061</NlmUniqueID><ISSNLinking>0066-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">antiviral efficacy</Keyword><Keyword MajorTopicYN="N">coxsackievirus B</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">natural product</Keyword><Keyword MajorTopicYN="N">trans-2-hexenoic acid</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36786598</ArticleId><ArticleId IdType="pmc">PMC10019289</ArticleId><ArticleId IdType="doi">10.1128/aac.00868-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tuthill TJ, Groppelli E, Hogle JM, Rowlands DJ. 2010. Picornaviruses. Curr Top Microbiol Immunol 343:43&#x2013;89. 10.1007/82_2010_37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/82_2010_37</ArticleId><ArticleId IdType="pmc">PMC3018333</ArticleId><ArticleId IdType="pubmed">20397067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball CC, Alirezaei M, Whitton JL. 2010. Type B coxsackieviruses and their interactions with the innate and adaptive immune systems. Future Microbiol 5:1329&#x2013;1347. 10.2217/fmb.10.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.10.101</ArticleId><ArticleId IdType="pmc">PMC3045535</ArticleId><ArticleId IdType="pubmed">20860480</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin J, Mangale V, Thienphrapa W, Gottlieb RA, Feuer R. 2015. Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. Virology 484:288&#x2013;304. 10.1016/j.virol.2015.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.06.006</ArticleId><ArticleId IdType="pmc">PMC4567421</ArticleId><ArticleId IdType="pubmed">26142496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhao S, Chen Y, Wang Y, Wang T, Wo X, Dong Y, Zhang J, Xu W, Qu C, Feng X, Wu X, Wang Y, Zhong Z, Zhao W. 2020. N-Acetyl cysteine effectively alleviates coxsackievirus B-induced myocarditis through suppressing viral replication and inflammatory response. Antiviral Res 179:104699. 10.1016/j.antiviral.2019.104699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.104699</ArticleId><ArticleId IdType="pubmed">31883926</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkimaa A, Sioofy-Khojine A-B, Oikarinen S, Bertin A, Hober D, Hy&#xf6;ty H. 2020. Eradication of persistent coxsackievirus B infection from a pancreatic cell line with clinically used antiviral drugs. J Clin Virol 128:104334. 10.1016/j.jcv.2020.104334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104334</ArticleId><ArticleId IdType="pubmed">32450550</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Lidsky PV, Shirogane Y, Aviner R, Wu CT, Li W, Zheng W, Talbot D, Catching A, Doitsh G, Su W, Gekko CE, Nayak A, Ernst JD, Brodsky L, Brodsky E, Rousseau E, Capponi S, Bianco S, Nakamura R, Jackson PK, Frydman J, Andino R. 2021. A defective viral genome strategy elicits broad protective immunity against respiratory viruses. Cell 184:6037&#x2013;6051.e14. 10.1016/j.cell.2021.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.023</ArticleId><ArticleId IdType="pmc">PMC8598942</ArticleId><ArticleId IdType="pubmed">34852237</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone VM, Butrym M, Hankaniemi MM, Sioofy-Khojine AB, Hyt&#xf6;nen VP, Hy&#xf6;ty H, Flodstr&#xf6;m-Tullberg M. 2021. Coxsackievirus B vaccines prevent infection-accelerated diabetes in NOD mice and have no disease-inducing effect. Diabetes 70:2871&#x2013;2878. 10.2337/db21-0193.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0193</ArticleId><ArticleId IdType="pmc">PMC8660981</ArticleId><ArticleId IdType="pubmed">34497136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhao S, Chen Y, Wang T, Dong C, Wo X, Zhang J, Dong Y, Xu W, Feng X, Qu C, Wang Y, Zhong Z, Zhao W. 2019. The capsid protein VP1 of coxsackievirus B induces cell cycle arrest by up-regulating heat shock protein 70. Front Microbiol 10:1633. 10.3389/fmicb.2019.01633.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01633</ArticleId><ArticleId IdType="pmc">PMC6653663</ArticleId><ArticleId IdType="pubmed">31379784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazzaro F, Fratianni F, Coppola R, De Feo V. 2017. Essential oils and antifungal activity. Pharmaceuticals (Basel) 10:86. 10.3390/ph10040086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph10040086</ArticleId><ArticleId IdType="pmc">PMC5748643</ArticleId><ArticleId IdType="pubmed">29099084</ArticleId></ArticleIdList></Reference><Reference><Citation>Treml J, Gazdov&#xe1; M, &#x160;mejkal K, &#x160;udomov&#xe1; M, Kubatka P, Hassan STS. 2020. Natural products-derived chemicals: breaking barriers to novel anti-HSV drug development. Viruses 12:154. 10.3390/v12020154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12020154</ArticleId><ArticleId IdType="pmc">PMC7077281</ArticleId><ArticleId IdType="pubmed">32013134</ArticleId></ArticleIdList></Reference><Reference><Citation>de C&#xe1;ssia da Silveira e S&#xe1; R, Lima TC, da N&#xf3;brega FR, de Brito AEM, de Sousa DP. 2017. Analgesic-like activity of essential oil constituents: an update. Int J Mol Sci 18:2392. 10.3390/ijms18122392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18122392</ArticleId><ArticleId IdType="pmc">PMC5751100</ArticleId><ArticleId IdType="pubmed">29232831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Shabat S, Yarmolinsky L, Porat D, Dahan A. 2020. Antiviral effect of phytochemicals from medicinal plants: applications and drug delivery strategies. Drug Deliv Transl Res 10:354&#x2013;367. 10.1007/s13346-019-00691-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13346-019-00691-6</ArticleId><ArticleId IdType="pmc">PMC7097340</ArticleId><ArticleId IdType="pubmed">31788762</ArticleId></ArticleIdList></Reference><Reference><Citation>Api AM, Belsito D, Biserta S, Botelho D, Bruze M, Burton GA, Jr, Buschmann J, Cancellieri MA, Dagli ML, Date M, Dekant W, Deodhar C, Fryer AD, Gadhia S, Jones L, Joshi K, Kumar M, Lapczynski A, Lavelle M, Lee I, Liebler DC, Moustakas H, Na M, Penning TM, Ritacco G, Romine J, Sadekar N, Schultz TW, Selechnik D, Siddiqi F, Sipes IG, Sullivan G, Thakkar Y, Tokura Y. 2021. RIFM fragrance ingredient safety assessment, 2-mercaptopropionic acid, CAS registry number 79-42-5. Food Chem Toxicol 149 Suppl 1:111987. 10.1016/j.fct.2021.111987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2021.111987</ArticleId><ArticleId IdType="pubmed">33460696</ArticleId></ArticleIdList></Reference><Reference><Citation>Alasalvar C, Topal B, Serpen A, Bahar B, Pelvan E, G&#xf6;kmen V. 2012. Flavor characteristics of seven grades of black tea produced in Turkey. J Agric Food Chem 60:6323&#x2013;6332. 10.1021/jf301498p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf301498p</ArticleId><ArticleId IdType="pubmed">22642545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DY, Lin X, Paskaleva EE, Liu Y, Puttamadappa SS, Thornber C, Drake JR, Habulin M, Shekhtman A, Canki M. 2009. Palmitic acid is a novel CD4 fusion inhibitor that blocks HIV entry and infection. AIDS Res Hum Retroviruses 25:1231&#x2013;1241. 10.1089/aid.2009.0019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.2009.0019</ArticleId><ArticleId IdType="pmc">PMC2828184</ArticleId><ArticleId IdType="pubmed">20001317</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai CL, Shi J, Chen Y, Iqbal K, Liu F, Gong CX. 2013. Inhibition of protein synthesis alters protein degradation through activation of protein kinase B (AKT). J Biol Chem 288:23875&#x2013;23883. 10.1074/jbc.M112.445148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.445148</ArticleId><ArticleId IdType="pmc">PMC3745334</ArticleId><ArticleId IdType="pubmed">23843462</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Zhong W. 2021. Mechanism of action of favipiravir against SARS-CoV-2: mutagenesis or chain termination? Innovation (Camb) 2:100165. 10.1016/j.xinn.2021.100165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2021.100165</ArticleId><ArticleId IdType="pmc">PMC8425668</ArticleId><ArticleId IdType="pubmed">34518821</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Q, Kopp SJ, Connolly SA, Longnecker R. 2017. Structure-based mutations in the herpes simplex virus 1 glycoprotein B ectodomain arm impart a slow-entry phenotype. mBio 8:e00614-17. 10.1128/mBio.00614-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00614-17</ArticleId><ArticleId IdType="pmc">PMC5433099</ArticleId><ArticleId IdType="pubmed">28512095</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitrov DS. 2004. Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol 2:109&#x2013;122. 10.1038/nrmicro817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro817</ArticleId><ArticleId IdType="pmc">PMC7097642</ArticleId><ArticleId IdType="pubmed">15043007</ArticleId></ArticleIdList></Reference><Reference><Citation>Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossmann MG. 1995. The structure of coxsackievirus B3 at 3.5 A resolution. Structure 3:653&#x2013;667. 10.1016/S0969-2126(01)00201-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(01)00201-5</ArticleId><ArticleId IdType="pubmed">8591043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail-Cassim N, Chezzi C, Newman JF. 1990. Inhibition of the uncoating of bovine enterovirus by short chain fatty acids. J Gen Virol 71:2283&#x2013;2289. 10.1099/0022-1317-71-10-2283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-71-10-2283</ArticleId><ArticleId IdType="pubmed">2172446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V, Goessling LS, Brar AK, Joshi CS, Mysorekar IU, Eghtesady P. 2021. Coxsackievirus B3 infection early in pregnancy induces congenital heart defects through suppression of fetal cardiomyocyte proliferation. J Am Heart Assoc 10:e017995. 10.1161/JAHA.120.017995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.017995</ArticleId><ArticleId IdType="pmc">PMC7955305</ArticleId><ArticleId IdType="pubmed">33440998</ArticleId></ArticleIdList></Reference><Reference><Citation>Habtemariam S. 2019. Natural products in Alzheimer's disease therapy: would old therapeutic approaches fix the broken promise of modern medicines? Molecules 24:1519. 10.3390/molecules24081519.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24081519</ArticleId><ArticleId IdType="pmc">PMC6514598</ArticleId><ArticleId IdType="pubmed">30999702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lica JJ, Wiecz&#xf3;r M, Grabe GJ, Heldt M, Jancz M, Misiak M, Gucwa K, Brankiewicz W, Maciejewska N, Stupak A, Bagi&#x144;ski M, Rolka K, Hellmann A, Sk&#x142;adanowski A. 2021. Effective drug concentration and selectivity depends on fraction of primitive cells. Int J Mol Sci 22:4931. 10.3390/ijms22094931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094931</ArticleId><ArticleId IdType="pmc">PMC8125035</ArticleId><ArticleId IdType="pubmed">34066491</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookheart RT, Michel CI, Schaffer JE. 2009. As a matter of fat. Cell Metab 10:9&#x2013;12. 10.1016/j.cmet.2009.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2009.03.011</ArticleId><ArticleId IdType="pmc">PMC2751821</ArticleId><ArticleId IdType="pubmed">19583949</ArticleId></ArticleIdList></Reference><Reference><Citation>Posimo JM, Unnithan AS, Gleixner AM, Choi AM, Jiang Y, Pulugulla SH, Leak RK. 2014. Viability assays for cells in culture. JoVE 83:e50645. 10.3791/50645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/50645</ArticleId><ArticleId IdType="pmc">PMC4089439</ArticleId><ArticleId IdType="pubmed">24472892</ArticleId></ArticleIdList></Reference><Reference><Citation>Limsuwat N, Boonarkart C, Phakaratsakul S, Suptawiwat O, Auewarakul P. 2020. Influence of cellular lipid content on influenza A virus replication. Arch Virol 165:1151&#x2013;1161. 10.1007/s00705-020-04596-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-020-04596-5</ArticleId><ArticleId IdType="pmc">PMC7223680</ArticleId><ArticleId IdType="pubmed">32227307</ArticleId></ArticleIdList></Reference><Reference><Citation>Goc A, Niedzwiecki A, Rath M. 2021. Polyunsaturated &#x3c9;-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Sci Rep 11:5207. 10.1038/s41598-021-84850-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84850-1</ArticleId><ArticleId IdType="pmc">PMC7933164</ArticleId><ArticleId IdType="pubmed">33664446</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorley JA, McKeating JA, Rappoport JZ. 2010. Mechanisms of viral entry: sneaking in the front door. Protoplasma 244:15&#x2013;24. 10.1007/s00709-010-0152-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00709-010-0152-6</ArticleId><ArticleId IdType="pmc">PMC3038234</ArticleId><ArticleId IdType="pubmed">20446005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohn A, Gitelman J, Inbar M. 1980. Unsaturated free fatty acids inactivate animal enveloped viruses. Arch Virol 66:301&#x2013;307. 10.1007/BF01320626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01320626</ArticleId><ArticleId IdType="pubmed">7447706</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth M, Pettitt T, Symonds A, Martin J. 2003. Identification of the pocket factors in a picornavirus. Arch Virol 148:1225&#x2013;1233. 10.1007/s00705-002-0974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-002-0974-4</ArticleId><ArticleId IdType="pubmed">12756627</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Yap ML, Cardosa J, Kuhn RJ, Rossmann MG. 2013. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci USA 110:5463&#x2013;5467. 10.1073/pnas.1222379110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippova EV, Zemaitaitis B, Aung T, Wolfe AJ, Anderson WF. 2018. Structural basis for DNA recognition by the two-component response regulator RcsB. mBio 9:e01993-17. 10.1128/mBio.01993-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01993-17</ArticleId><ArticleId IdType="pmc">PMC5829831</ArticleId><ArticleId IdType="pubmed">29487239</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. 2018. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 16:368&#x2013;381. 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjom&#xe4;ki V, Turkki P, Huttunen M. 2015. Infectious entry pathway of enterovirus B species. Viruses 7:6387&#x2013;6399. 10.3390/v7122945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122945</ArticleId><ArticleId IdType="pmc">PMC4690868</ArticleId><ArticleId IdType="pubmed">26690201</ArticleId></ArticleIdList></Reference><Reference><Citation>Helenius A. 2018. Virus entry: looking back and moving forward. J Mol Biol 430:1853&#x2013;1862. 10.1016/j.jmb.2018.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.03.034</ArticleId><ArticleId IdType="pmc">PMC7094621</ArticleId><ArticleId IdType="pubmed">29709571</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>